Steven Maximus

Steven Maximus

Auto-generated profile, based on publicly available information

Steven Maximus

Division of Vascular Surgery and Endovascular Therapy, Center for Aortic Surgery, Baylor College of Medicine, Houston, TX

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2024 in Journal of Vascular Surgery
Verified
Journal Article
Open access
KDKathryn L. DiLosa
Kathryn L. DiLosa
MMMichelle Manesh
Michelle Manesh
LKLucas Ruiter Kanamori
Lucas Ruiter Kanamori
MCMabel Chan
Mabel Chan
GMGregory A. Magee
Gregory A. Magee
SMSteven Maximus
Steven Maximus
The thoracic branch endoprosthesis (TBE) (W.L. Gore) offers an off-the-shelf single option for thoracic endovascular aortic repair (TEVAR) of aortic arch pathology with sealing in zones 0 to 2. This study reports the early outcomes of TBE-TEVAR for acute indications. Clinical data, imaging, and outcomes of patients treated with TBE-TEVAR at seven institutions were retrospectively reviewed (March 2017 to March 2024). Patients treated for complicated aortic dissection, symptomatic aneurysm/pseudoaneurysm, or blunt traumatic aortic injury by urgent/emergent repair were included. End points were 30-day mortality, major adverse events (mortality, myocardial infarction, prolonged intubation, stroke, paraplegia, dialysis, or bowel ischemia), and technical success. Of 356 patients treated by TBE-TEVAR, 107 (69.0% male; mean age, 60 ± 15 years) underwent repair for acute indications including 70 dissections (65%), 21 symptomatic aneurysms/pseudoaneurysms (20%), and 16 blunt traumatic aortic injuries (15%). Eight patients (8%) had repair immediately after open ascending repair of a type A dissection. Proximal sealing was in zone 2 in 91 patients (89%) and zone 0 to 1 in 11 patients (11%) who required cervical debranching. Technical success was achieved in all (99%) except one patient with acute dissection and aneurysmal degeneration requiring staged repair. At 30 days, two patients (2%) died, and 19 patients (18%) developed major adverse events, including stroke in six patients (6%) and paraplegia in six patients (6%). Five patients (5%; all Zone 2) had retrograde dissections, all treated for acute or subacute dissection, with no mortality. Mean follow-up was 55 ± 171 days, and 96 patients (94%) had follow-up imaging. Type IA or III endoleak occurred in seven patients (7%), retrograde branch occlusion in one (1%), and eleven (10%) required reintervention. Cumulative aortic-related mortality was three (3%) from aortic rupture. Urgent/emergent TEVAR with the Gore TBE device in acute pathology offers low mortality, stroke, and paraplegia risk. Longer follow-up is needed to assess effectiveness of the repair.

2 November 2023 in Journal of Vascular Surgery Cases, Innovations and Techniques
Verified
Journal Article
Open access
KDKathryn DiLosa
Kathryn DiLosa
CPCara Pozolo
Cara Pozolo
THThomas Heafner
Thomas Heafner
MHMisty Humphries
Misty Humphries
MKMimmie Kwong
Mimmie Kwong
SMSteven Maximus
Steven Maximus
The Gore TAG thoracic branch endoprosthesis (TBE) is the first Food and Drug Administration–approved device for zone 2 thoracic endovascular aortic repair, allowing for graft placement proximal to the left subclavian artery origin and maintaining vessel patency through a side branch. We describe our experience with the Gore TBE device in 20 patients for acute indications, including blunt thoracic aortic injuries, complicated dissections, and ruptured aneurysms. Technical success, with exclusion of pathology and left subclavian patency, was 100% without major complications within 30 days. Our early Gore TBE device experience demonstrates safe use in acute aortic pathology without an increased risk of complications.

1 May 2016 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
HYHuan Yan
Huan Yan
SMSteven Maximus
Steven Maximus
MKMatthew Koopmann
Matthew Koopmann
JKJessica Keeley
Jessica Keeley
BSBrian Smith
Brian Smith
DKDennis Y. Kim
Dennis Y. Kim

31 October 2022 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
SMSteven Maximus
Steven Maximus
MKMimmie Kwong
Mimmie Kwong
JHJoel Harding
Joel Harding
MMMatthew Mell
Matthew Mell

1 April 2016 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
SMSteven Maximus
Steven Maximus
JMJeffrey C. Milliken
Jeffrey C. Milliken
BDBeate Danielsen
Beate Danielsen
JKJunaid Khan
Junaid Khan
RSRichard Shemin
Richard Shemin
JCJoseph S. Carey
Joseph S. Carey

4 January 2018 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
SMSteven Maximus
Steven Maximus
JMJeffrey C. Milliken
Jeffrey C. Milliken
BDBeate Danielsen
Beate Danielsen
RSRichard Shemin
Richard Shemin
JKJunaid Khan
Junaid Khan
JCJoseph S. Carey
Joseph S. Carey